Ausgabe 10/2018
Inhalt (33 Artikel)
Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression
Erika Costa de Alvarenga, Walison N. Silva, Rebecca Vasconcellos, Edgar J. Paredes-Gamero, Akiva Mintz, Alexander Birbrair
Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients
Marius Bill, Juliane Grimm, Madlen Jentzsch, Laura Kloss, Karoline Goldmann, Julia Schulz, Stefanie Beinicke, Janine Häntschel, Michael Cross, Vladan Vucinic, Wolfram Pönisch, Gerhard Behre, Georg-Nikolaus Franke, Thoralf Lange, Dietger Niederwieser, Sebastian Schwind
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
Luca Maurillo, Francesco Buccisano, Alessandra Spagnoli, Maria Teresa Voso, Luana Fianchi, Cristina Papayannidis, Gian Luca Gaidano, Massimo Breccia, Pellegrino Musto, Eleonora De Bellis, Maria Ilaria Del Principe, Monia Lunghi, Federica Lessi, Giovanni Martinelli, Adriano Venditti
Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1
Huifei Liu, Sa A. Wang, Ellen J. Schlette, Jie Xu, Jeffrey L. Jorgensen, C. Cameron Yin, Shaoying Li, L. Jeffrey Medeiros, Guilin Tang
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials
Frédéric Baron, Marian Stevens-Kroef, Michal Kicinski, Giovanna Meloni, Petra Muus, Jean-Pierre Marie, Constantijn J. M. Halkes, Xavier Thomas, Radovan Vrhovac, Giorgina Specchia, Francois Lefrere Sr, Simona Sica, Marco Mancini, Adriano Venditti, Anne Hagemeijer, Heiko Becker, Joop H. Jansen, Sergio Amadori, Theo de Witte, Roelof Willemze, Stefan Suciu
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy
Laura Cicconi, Massimo Breccia, Luca Franceschini, Roberto Latagliata, Matteo Molica, Mariadomenica Divona, Daniela Diverio, Manuela Rizzo, Tiziana Ottone, Licia Iaccarino, Valentina Alfonso, Robin Foa, Maria Teresa Voso, Francesco Lo-Coco
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events
Matteo Molica, Emilia Scalzulli, Gioia Colafigli, Danilo Alunni Fegatelli, Fulvio Massaro, Roberto Latagliata, Robin Foà, Massimo Breccia
Reduced-dose EPOCH-R chemotherapy for elderly patients with advanced stage diffuse large B cell lymphoma
Wen-Hao Zhang, Gao-Yang Li, Yu-Jie Ma, Zhi-Chao Li, Yang Zhu, Jun Chang, Si-Guo Hao, Rong Tao
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP)
Vincenzo Pavone, Anna Mele, Daniela Carlino, Giorgina Specchia, Francesco Gaudio, Tommasina Perrone, Patrizio Mazza, Giulia Palazzo, Attilio Guarini, Giacomo Loseto, Prete Eleonora, Nicola Cascavilla, Potito Scalzulli, Angela Melpignano, Giovanni Quintana, Nicola Di Renzo, Giuseppe Tarantini, Silvana Capalbo
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
Alexander Egle, Michael Steurer, Thomas Melchardt, Lukas Weiss, Franz Josef Gassner, Nadja Zaborsky, Roland Geisberger, Kemal Catakovic, Tanja Nicole Hartmann, Lisa Pleyer, Daniela Voskova, Josef Thaler, Alois Lang, Michael Girschikofsky, Andreas Petzer, Richard Greil
Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma
Jun-Ying Niu, Tian Tian, Hua-Yuan Zhu, Jin-Hua Liang, Wei Wu, Lei Cao, Rui-Nan Lu, Li Wang, Jian-Yong Li, Wei Xu
Treating synchronous bilateral ocular adnexal marginal zone lymphoma: the consortium for improving survival of lymphoma study
Sung Yong Oh, Won Seog Kim, Hye-Jin Kang, Ji Hyun Lee, Seok Jae Huh, Seok Jin Kim, Dok Hyun Yoon, Jung Yong Hong, Won Sik Lee, Hyo Jung Kim, Jong Ho Won, Byeong-Bae Park, Soon II Lee, Cheolwon Suh
Diagnosis of Richter transformation in chronic lymphocytic leukemia: histology tips the scales
Birgit Federmann, Martin R. Mueller, Julia Steinhilber, Marius S. Horger, Falko Fend
Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma
Mukul Aggarwal, Narendra Agrawal, Neha Yadav, Priyanka Verma, Rayaz Ahmed, Pallavi Mehta, Jyotsna Kapoor, Dinesh Bhurani
High chymotrypsin-like activity in the plasma of patients with newly diagnosed multiple myeloma treated with bortezomib is predictive of a better response and longer PFS
Wioletta Romaniuk, Lukasz Bolkun, Joanna Kalita, Marzenna Galar, Malgorzata Bernatowicz, Halina Ostrowska, Janusz Kloczko
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
Andreas Tiede, Andrew Worster
The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study
Zara Forbrigger, Stefan Kuhle, Mary Margaret Brown, Paul C. Moorehead, Carol Digout, Ketan Kulkarni
Red blood cells metabolome changes upon treatment with different X-ray irradiation doses
Fabio Baroni, Chiara Marraccini, Lucia Merolle, Vando Piccagli, Daniele Lambertini, Mauro Iori, Tommaso Fasano, Emanuela Casali, Alberto Spisni, Roberto Baricchi, Thelma A. Pertinhez
Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia
Sezaneh Haghpanah, Tahereh Zarei, Peyman Eshghi, Omidreza Zekavat, Mohammadreza Bordbar, Mahmood Hoormand, Mehran Karimi
The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network
Paolo Ricchi, Antonella Meloni, Laura Pistoia, Anna Spasiano, Alessandra Spiga, Massimo Allò, Maria Rita Gamberini, Roberto Lisi, Saveria Campisi, Angelo Peluso, Massimiliano Missere, Stefania Renne, Maurizio Mangione, Vincenzo Positano, Alessia Pepe
Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia
Quan Ren, Ya-Li Zhou, Li Wang, Yong-Sheng Chen, Yan-Ni Ma, Ping-Ping Li, Xiao-Lin Yin
Efficacy and safety of mesenchymal stromal cells for the prophylaxis of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials
Li Wang, Cheng-ying Zhu, De-xun Ma, Zhen-yang Gu, Chang-chun Xu, Fei-yan Wang, Ji-gang Chen, Cheng-jun Liu, Li-xun Guan, Rui Gao, Zhe Gao, Shu Fang, Du-jun Zhuo, Shu-feng Liu, Chun-ji Gao
Outcome of gastrointestinal graft-versus-host disease according to the treatment response
Masaharu Tamaki, Hideki Nakasone, Yukiko Misaki, Kazuki Yoshimura, Ayumi Gomyo, Jin Hayakawa, Machiko Kusuda, Yu Akahoshi, Yuko Ishihara, Koji Kawamura, Aki Tanihara, Miki Sato, Kiriko Terasako-Saito, Kazuaki Kameda, Hidenori Wada, Misato Kikuchi, Shun-ichi Kimura, Shinichi Kako, Yoshinobu Kanda
Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency—a case report and comprehensive review of the literature
Alexander Simonis, Michaela Fux, Gayathri Nair, Nicolas J. Mueller, Eugenia Haralambieva, Thomas Pabst, Jana Pachlopnik Schmid, Adrian Schmidt, Urs Schanz, Markus G Manz, Antonia M. S. Müller
Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in older patients undergoing allogeneic hematopoietic cell transplant for myeloid malignancies
Manar M. I. Khalil, Hans A. Messner, Jeffrey H. Lipton, Dennis D. Kim, Auro Viswabandya, Santhosh Thyagu, Uday Deotare, Fotios V. Michelis
Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study
Ioanna Sakellari, Eleni Gavriilaki, Konstantinos Chatziioannou, Maria Papathanasiou, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Stella Bouziana, Varnavas Constantinou, Vassiliki Douka, Chrysa Apostolou, Michalis Iskas, Chrysavgi Lalayanni, Anastasia Athanasiadou, Damianos Sotiropoulos, Evangelia Yannaki, Vasilis Gianouzakos, Achilles Anagnostopoulos
A portion of expanded granular lymphocytes cause pure white cell aplasia?
Yasushi Isobe, Yu Uemura, Akiko Uchida, Ikuo Miura
Monotypic and IgH-rearranged lymphoplasmacytic cells restricted to the light zone of germinal centers: an early (in situ?) marginal zone lymphoma?
Jennifer Chapman, Francisco Vega
Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine
Greta Scapinello, Marco Pizzi, Stefania Vio, Mitja Nabergoj, Andrea Visentin, Annalisa Martines, Laura Bonaldi, Livio Trentin, Gianpietro Semenzato, Francesco Piazza
Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis
Stefano Molica, Diana Giannarelli, Rosanna Mirabelli, Luciano Levato, Tait D. Shanafelt
A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment
Yuriko Fujita, Tomonori Nakazato, Chisako Ito, Kyoko Masuda, Yuki Osada, Yoshinobu Aisa, Takehiko Mori
Bilateral adrenal hemorrhage as a manifestation of extramedullary hematopoiesis in a patient with primary myelofibrosis
Kelsey Uminski, Rajat Kumar, Matthew Seftel
Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
Satoshi Yamasaki, Dai Chihara, Sung-Won Kim, Koji Izutsu, Kouji Iwato, Takahiro Fukuda, Naoyuki Uchida, Itsuto Amano, Hideyuki Nakazawa, Junya Kuroda, Hisako Hashimoto, Tatsuo Ichinohe, Yoshinobu Kanda, Yoshiko Atsuta, Junji Suzumiya, Ritsuro Suzuki